AU2003233009A8 - A human cell assay to determine effect of sample compounds on col2 enhancer expression - Google Patents

A human cell assay to determine effect of sample compounds on col2 enhancer expression

Info

Publication number
AU2003233009A8
AU2003233009A8 AU2003233009A AU2003233009A AU2003233009A8 AU 2003233009 A8 AU2003233009 A8 AU 2003233009A8 AU 2003233009 A AU2003233009 A AU 2003233009A AU 2003233009 A AU2003233009 A AU 2003233009A AU 2003233009 A8 AU2003233009 A8 AU 2003233009A8
Authority
AU
Australia
Prior art keywords
col2
human cell
cell assay
sample compounds
determine effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003233009A
Other versions
AU2003233009A1 (en
Inventor
Jean Frances Schaefer
Leonard Buckbinder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of AU2003233009A8 publication Critical patent/AU2003233009A8/en
Publication of AU2003233009A1 publication Critical patent/AU2003233009A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003233009A 2002-06-04 2003-05-26 A human cell assay to determine effect of sample compounds on col2 enhancer expression Abandoned AU2003233009A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38615602P 2002-06-04 2002-06-04
US60/386,156 2002-06-04
PCT/IB2003/002256 WO2003102130A2 (en) 2002-06-04 2003-05-26 A human cell assay to determine effect of sample compounds on col2 enhancer expression

Publications (2)

Publication Number Publication Date
AU2003233009A8 true AU2003233009A8 (en) 2003-12-19
AU2003233009A1 AU2003233009A1 (en) 2003-12-19

Family

ID=29712234

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003233009A Abandoned AU2003233009A1 (en) 2002-06-04 2003-05-26 A human cell assay to determine effect of sample compounds on col2 enhancer expression

Country Status (7)

Country Link
EP (1) EP1576098A2 (en)
JP (1) JP2006500915A (en)
AU (1) AU2003233009A1 (en)
BR (1) BR0311594A (en)
CA (1) CA2488006A1 (en)
MX (1) MXPA04012042A (en)
WO (1) WO2003102130A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8791084B2 (en) 2006-10-27 2014-07-29 Robarts Research Institute Inhibition of SOX9 function in the treatment of proteoglycan-associated pathophysiological conditions
KR102084227B1 (en) * 2018-09-05 2020-03-03 (주)루젠에스씨아이 Human transformed chondrocyte cell line mediated drug screening system for cartilage disease remedy

Also Published As

Publication number Publication date
BR0311594A (en) 2007-04-27
MXPA04012042A (en) 2005-03-07
WO2003102130A3 (en) 2006-06-22
AU2003233009A1 (en) 2003-12-19
EP1576098A2 (en) 2005-09-21
WO2003102130A2 (en) 2003-12-11
CA2488006A1 (en) 2003-12-11
JP2006500915A (en) 2006-01-12

Similar Documents

Publication Publication Date Title
AU2003251351A1 (en) Detection of disease by analysis of emissions
AU2003221808A1 (en) Analyte sensor
AU2003210829A8 (en) Battery-powered wristwatch
AU2003287735A1 (en) Non-invasive measurement of analytes
EP1535930A4 (en) Antibody specific to central tetra-protein
EP1511408A4 (en) Cross reference to related art
AU2003290798A1 (en) Body fat scale having transparent electrodes
AU2003205913A1 (en) Materials and methods relating to cancer diagnosis
AU2003242251A1 (en) Kit for assay development and serial analysis
AU2003299715A1 (en) Compounds for the normalization of the sleep/wake cycle
AU2003206882A1 (en) Analysis of vital substances
GB0307352D0 (en) Improvements in and relating to the analysis of compounds
AU2003233009A8 (en) A human cell assay to determine effect of sample compounds on col2 enhancer expression
AU2003226401A8 (en) Gelsolin as a prognostic marker of artherosclerotic diseases
GB0219345D0 (en) Improvements in or relating to organic compounds
AU2003222371A1 (en) Use of a capacitive probe to determine the biomass of small bacteria
AU2002951622A0 (en) Improvements relating to treatment of waste materials
AUPS239302A0 (en) Improvements to tow-bars
GB0210159D0 (en) Improvements relating to signal enhancement
AU2002360490A1 (en) The use of quantitative evolutionary trace analysis to determine functional residues
AU2003299746A1 (en) Total synthesis of daurichromenic acid
AU2003295335A1 (en) Thermal analysis of energetic materials
AU2003259805A8 (en) Methods of producing electrodes and methods of using such electrodes to accumulate and detect analytes
AU2003279550A1 (en) Scaffolds useful to the synthesis of compounds with biological activity
GB2392604B (en) Improvements to and relating to studded footwear

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase